Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Released Aug 14, 2015, after the close
10-Q filed Aug 14, 2015, 45 days after period end · 0001640334-15-000037
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2015 | Q2 2014 | Q2 2012 |
|---|---|---|---|
| Net Income | -$2.06M | -$142.92K | -$381.00 |
| EPS Diluted | -$0.13 | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 14, 2015 · 45 d after period end
